121 related articles for article (PubMed ID: 38881666)
1. Development of a colloidal gold-based immunochromatographic assay for rapid detection of nasal mucosal secretory IgA against SARS-CoV-2.
Sun B; Chen Z; Feng B; Chen S; Feng S; Wang Q; Niu X; Zhang Z; Zheng P; Lin M; Luo J; Pan Y; Guan S; Zhong N; Chen L
Front Microbiol; 2024; 15():1386891. PubMed ID: 38881666
[TBL] [Abstract][Full Text] [Related]
2. Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum.
Bladh O; Aguilera K; Marking U; Kihlgren M; Greilert Norin N; Smed-Sörensen A; Sällberg Chen M; Klingström J; Blom K; Russell MW; Havervall S; Thålin C; Åberg M
Front Immunol; 2024; 15():1346749. PubMed ID: 38558811
[TBL] [Abstract][Full Text] [Related]
3. Detection of SARS-CoV-2-Specific Secretory IgA and Neutralizing Antibodies in the Nasal Secretions of Exposed Seronegative Individuals.
Chwa JS; Kim M; Lee Y; Cheng WA; Shin Y; Jumarang J; Bender JM; Pannaraj PS
Viruses; 2024 May; 16(6):. PubMed ID: 38932145
[TBL] [Abstract][Full Text] [Related]
4. The Secretory IgA Response in Human Milk Against the SARS-CoV-2 Spike Is Highly Durable and Neutralizing for At Least 1 Year of Lactation Postinfection.
Yang X; Fox A; DeCarlo C; Pineda N; Powell RLR
Breastfeed Med; 2023 Aug; 18(8):602-611. PubMed ID: 37615565
[No Abstract] [Full Text] [Related]
5. Nasal mucosal IgA levels against SARS-CoV-2 and seasonal coronaviruses are low in children but boosted by reinfection.
Dowell AC; Tut G; Begum J; Bruton R; Bentley C; Butler M; Uwenedi G; Zuo J; Powell AA; Brent AJ; Brent B; Baawuah F; Okike I; Beckmann J; Ahmad S; Aiano F; Garstang J; Ramsay ME; Moss P; Ladhani SN
J Infect; 2023 Nov; 87(5):403-412. PubMed ID: 37660754
[TBL] [Abstract][Full Text] [Related]
6. Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study.
Tan CY; Chiew CJ; Pang D; Lee VJ; Ong B; Lye DC; Tan KB
Lancet Infect Dis; 2023 Jul; 23(7):799-805. PubMed ID: 36924786
[TBL] [Abstract][Full Text] [Related]
7. In Vivo Antiviral Efficacy of LCTG-002, a Pooled, Purified Human Milk Secretory IgA product, Against SARS-CoV-2 in a Murine Model of COVID-19.
Mane V; Mehta R; Alvarez N; Sharma V; Park S; Fox A; DeCarlo C; Yang X; Perlin DS; Powell RLR
bioRxiv; 2023 Aug; ():. PubMed ID: 37693438
[TBL] [Abstract][Full Text] [Related]
8. The secretory IgA (sIgA) response in human milk against the SARS-CoV-2 Spike is highly durable and neutralizing for at least 1 year of lactation post-infection.
Yang X; Fox A; DeCarlo C; Pineda N; Powell RLR
medRxiv; 2023 May; ():. PubMed ID: 37293109
[TBL] [Abstract][Full Text] [Related]
9. Intranasal booster using an Omicron vaccine confers broad mucosal and systemic immunity against SARS-CoV-2 variants.
Wang Q; Yang C; Yin L; Sun J; Wang W; Li H; Zhang Z; Chen S; Liu B; Liu Z; Shi L; Liu X; Guan S; Wang C; Qu L; Feng Y; Niu X; Feng L; Zhao J; Li P; Chen L; Zhong N
Signal Transduct Target Ther; 2023 Apr; 8(1):167. PubMed ID: 37069171
[TBL] [Abstract][Full Text] [Related]
10. In vivo antiviral efficacy of LCTG-002, a pooled, purified human milk secretory IgA product, against SARS-CoV-2 in a murine model of COVID-19.
Mane V; Mehta R; Alvarez N; Sharma V; Park S; Fox A; DeCarlo C; Yang X; Perlin DS; Powell RLR
Hum Vaccin Immunother; 2024 Dec; 20(1):2303226. PubMed ID: 38251677
[TBL] [Abstract][Full Text] [Related]
11. Detection of cross-reactive immunoglobulin A against the severe acute respiratory syndrome-coronavirus-2 spike 1 subunit in saliva.
Tsukinoki K; Yamamoto T; Handa K; Iwamiya M; Saruta J; Ino S; Sakurai T
PLoS One; 2021; 16(11):e0249979. PubMed ID: 34813596
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the mucosal and systemic antibody responses in Covid-19 recovered patients with one dose of mRNA vaccine and unexposed subjects with three doses of mRNA vaccines.
Liu S; Tsun JGS; Fung GPG; Lui GCY; Chan KYY; Chan PKS; Chan RWY
Front Immunol; 2023; 14():1127401. PubMed ID: 36793736
[TBL] [Abstract][Full Text] [Related]
13. Development of a rapid immunochromatographic strip test for the detection of porcine epidemic diarrhea virus specific SIgA in colostrum.
Liu J; Gao R; Shi H; Cong G; Chen J; Zhang X; Shi D; Cao L; Wang X; Zhang J; Ji Z; Jing Z; Feng L
J Virol Methods; 2020 May; 279():113855. PubMed ID: 32173373
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination.
Liew F; Talwar S; Cross A; Willett BJ; Scott S; Logan N; Siggins MK; Swieboda D; Sidhu JK; Efstathiou C; Moore SC; Davis C; Mohamed N; Nunag J; King C; Thompson AAR; Rowland-Jones SL; Docherty AB; Chalmers JD; Ho LP; Horsley A; Raman B; Poinasamy K; Marks M; Kon OM; Howard L; Wootton DG; Dunachie S; Quint JK; Evans RA; Wain LV; Fontanella S; de Silva TI; Ho A; Harrison E; Baillie JK; Semple MG; Brightling C; Thwaites RS; Turtle L; Openshaw PJM; ;
EBioMedicine; 2023 Jan; 87():104402. PubMed ID: 36543718
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responses.
Puhach O; Bellon M; Adea K; Bekliz M; Hosszu-Fellous K; Sattonnet P; Hulo N; Kaiser L; Eckerle I; Meyer B
EBioMedicine; 2023 Dec; 98():104893. PubMed ID: 38035462
[TBL] [Abstract][Full Text] [Related]
16. Salivary and serum IgA and IgG responses to SARS-CoV-2-spike protein following SARS-CoV-2 infection and after immunization with COVID-19 vaccines.
Li D; Calderone R; Nsouli TM; Reznikov E; Bellanti JA
Allergy Asthma Proc; 2022 Sep; 43(5):419-430. PubMed ID: 36065108
[No Abstract] [Full Text] [Related]
17. Salivary anti-SARS-CoV-2 IgA as an accessible biomarker of mucosal immunity against COVID-19.
Varadhachary A; Chatterjee D; Garza J; Garr RP; Foley C; Letkeman A; Dean J; Haug D; Breeze J; Traylor R; Malek A; Nath R; Linbeck L
medRxiv; 2020 Aug; ():. PubMed ID: 32817976
[TBL] [Abstract][Full Text] [Related]
18. Immune response and severity of Omicron BA.5 reinfection among individuals previously infected with different SARS-CoV-2 variants.
Li L; Xie Z; Li Y; Luo M; Zhang L; Feng C; Tang G; Huang H; Hou R; Xu Y; Jia S; Shi J; Fan Q; Gan Q; Yu N; Hu F; Li Y; Lan Y; Tang X; Li F; Deng X
Front Cell Infect Microbiol; 2023; 13():1277880. PubMed ID: 38188634
[TBL] [Abstract][Full Text] [Related]
19. Transmission and Protection against Reinfection in the Ferret Model with the SARS-CoV-2 USA-WA1/2020 Reference Isolate.
Patel DR; Field CJ; Septer KM; Sim DG; Jones MJ; Heinly TA; Vanderford TH; McGraw EA; Sutton TC
J Virol; 2021 Jun; 95(13):e0223220. PubMed ID: 33827954
[TBL] [Abstract][Full Text] [Related]
20. Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5.
Diem G; Jäger M; Dichtl S; Bauer A; Lass-Flörl C; Reindl M; Wilflingseder D; Posch W
Microbiol Spectr; 2023 Jun; 11(3):e0516322. PubMed ID: 37098903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
